Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christ

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognitionC S Probert, A D Christ, L J Saubermann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 31, 2004
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and applicationHarvey Wong, Scott J Grossman, Stephen A Bai, et al.
Gut|June 20, 2001
Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonistP Hildebrand, F S Lehmann, S Ketterer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytesA Anumanthan, A Bensussan, L Boumsell, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartanM R Goldberg, M W Lo, D D Christ, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2009
Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonistsRainer E Martin, Peter Mohr, Hans Peter Maerki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiographyEric G Solon, Suresh K Balani, Gang Luo, et al.
Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognitionC S Probert, A D Christ, L J Saubermann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 31, 2004
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and applicationHarvey Wong, Scott J Grossman, Stephen A Bai, et al.
Gut|June 20, 2001
Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonistP Hildebrand, F S Lehmann, S Ketterer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytesA Anumanthan, A Bensussan, L Boumsell, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartanM R Goldberg, M W Lo, D D Christ, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2009
Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonistsRainer E Martin, Peter Mohr, Hans Peter Maerki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiographyEric G Solon, Suresh K Balani, Gang Luo, et al.
Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Pageof 12